Live · 05 Oct 2026 SPX 7,722.72 +0.73% NDX 30,807.93 +1.00% VIX 16.35 +6.79% GOLD 4,196.00 +0.81% CL 90.12 -1.09% BTC 86,156.27 -0.37%
NAS100 30,808 +1.00% S&P 7,723 +0.73% GOLD $4,196 +0.81% BTC $86,156 −0.37% VIX 16.35 +6.79% live tape · as of 09:01 UTC
The Screen · Basic Materials · Specialty Chemicals

Victrex plc

VCT.L · LSE · GBp · Market cap $85.6B · 1,169 employees

Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide.

PASS · Titan Ethical · score 70.0
983.00 GBp

Screen close, 2026-09-21 · not a live quote
Last reviewed 14 days ago

Screened 2026-09-21 · the tape above runs as of 09:01 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

PRICE · FAIR-VALUE RANGE1M3M6MYTD1Y3Y5Y
491.50491.50491.50

What this means: price 983.00 against the desk's fair-value range, base estimate 491.50, over the last year.

Current read
Markup ?
Screened · screened 2026-09-21
  • Trend Markup
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options no verdict drawn today, left as found
  • Ethical passes the values gate
Price983.00 GBp
Fair value491.50
Ethical score70.0/100
Our investment reviews on this name
2026-09-16Read Markup620.00+58.5% to today ✓
2026-07-02Read Accumulation620.00+58.5% to today ✓

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its markup label.

Victrex plc holds its Markup at $983.00. The statistical read favours the sellers, held for 81 days.

As held on the ledger · 2026-09-21
PhaseMarkup
Quantitative stateThe statistical read favours the sellers, held for 81 days
Price at the screen$983.00
ValuationN/A trailing · 2,022.22 forward price to earnings
Values screenPASS · score 70.0
Beta0.76
The Workings

Five Screens, Shown in Full

Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.

TestFigureLimitWhat it meansStatus
Business activity Permissible Core business clean Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
Debt load 8.64% Below 33% Interest-bearing debt is just 8.6% of its assets, well under the one-third ceiling: it does not run on borrowed money. Pass
Interest-bearing cash 0.18% Below 33% Cash held in interest-bearing accounts and securities is 0.2% of assets, under the one-third limit. Pass
Receivables 10.18% Below 49% Money owed to the company is 10.2% of assets, under the 49% limit. Pass
Revenue purity 0.13% Below 5% Only 0.1% of revenue comes from non-compliant sources, under the 5% line. Pass

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Clears, in Plain English

Victrex clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 9%, inside the ~33% line, and almost none of its income is interest, so it passes.

Read as at 2026-10-04. It updates when the underlying figures move, and past reads are kept below.

What the Numbers Say It Is Worth

The Fair Value Range

491.50Conservative491.50Base case491.50Growth case 983.00Price

Fair value range in GBp, drawn from the 2026-09-21 screen. The gold marker is the market price at the same screen. The price runs 50.0% above the base estimate.

The Street's Range
575.00Street low 625.00Street average 870.00Street high 983.00Price

Third-party analyst targets: 13 covering, consensus Hold. The average target sits −36% from the screen price.

Reading the gap · Both our model and the Street see limited upside at this price.

Price History & Projections
$2,679$1,504$329TODAY5y agoPROJECTIONStreet high$870.00 +44%Street avg$625.00 +3%Conservative$491.50 -19%Our fair value$491.50 -19%

Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-21 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words
The fundamentals · plain-English read
Forward P/E2,022.2xexpensive even after accounting for its growth
EPS, trailing-0.22
EPS, forward0.49
Revenue growth+0.8%slow but positive growth
Profit margin-6.7%currently unprofitable
Return on equity-9.4%not currently earning a positive return on equity
FCF yield8.59%
Dividend yield961.00%
Debt to equity0.22minimal debt: a conservative balance sheet
Current ratio2.35comfortably covers its short-term bills
Beta0.76steadier than the market
52-week range515.00 - 805.00
Market cap$85.6B
Employees1,169

The risks · The things to watch: its business and earnings are exposed to United Kingdom and to currency swings.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

VCT.L trades on LSE (the company is based in United Kingdom). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-10-02 Markup $983.00 +58.5% Entry 6

The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 58.5% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 11%. The street (13 analysts) rates it hold, with a mean price target of $679. Since the last review it its composite score eased.

2026-09-16 Markup · changed $620.00 +0.0% Entry 5

The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 11%. The street (13 analysts) rates it hold, with a mean price target of $679.

2026-08-16 Accumulation $620.00 +0.0% Entry 4

The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 11%. The street (13 analysts) rates it hold, with a mean price target of $679.

2026-07-18 Accumulation $620.00 +0.0% Entry 3

The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 11%. The street (13 analysts) rates it hold, with a mean price target of $679.

2026-07-03 Accumulation $620.00 +0.0% Entry 2

The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.

2026-07-02 Accumulation $620.00 Entry 1

The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $582.88 +3.8% $13.42 $1,061 +6.1%
2 months $619.87 -2.4% $13.42 $998 -0.2%
3 months $619.87 -2.4% $13.42 $998 -0.2%
6 months $653.45 -7.4% $59.56 $1,017 +1.7%
1 year $806.33 -25.0% $59.56 $824 -17.6%
2 years $1,250.20 -51.6% $119.12 $579 -42.1%
3 years $1,521.13 -60.2% $178.68 $515 -48.5%
5 years $2,517.05 -76.0% $347.80 $379 -62.1%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever VCT.L does next, these words stay.

Victrex plc · VCT.L · Markup · $983.00
Recorded 2026-09-21 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.